Last reviewed · How we verify
Combined Depo-Medrone and Lidocaine
Combined Depo-Medrone and Lidocaine is a Small molecule drug developed by Barts & The London NHS Trust. It is currently FDA-approved. Also known as: Methylprednisolone Acetate BP 40mg/mL:, Lidocaine Hydrochloride 2%:.
At a glance
| Generic name | Combined Depo-Medrone and Lidocaine |
|---|---|
| Also known as | Methylprednisolone Acetate BP 40mg/mL:, Lidocaine Hydrochloride 2%: |
| Sponsor | Barts & The London NHS Trust |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Conservative Treatment in Patients With Supraspinatus Tendon Injury. (NA)
- Transforaminal Epidural Injection in Acute Sciatica (NA)
- A Study Investigating the Efficacy of GON Blocks. (PHASE4)
- Optimal Treatment of Plantar Fasciitis: Physical Training, Glucocorticoid Injections or a Combination Thereof. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Combined Depo-Medrone and Lidocaine CI brief — competitive landscape report
- Combined Depo-Medrone and Lidocaine updates RSS · CI watch RSS
- Barts & The London NHS Trust portfolio CI
Frequently asked questions about Combined Depo-Medrone and Lidocaine
What is Combined Depo-Medrone and Lidocaine?
Combined Depo-Medrone and Lidocaine is a Small molecule drug developed by Barts & The London NHS Trust.
Who makes Combined Depo-Medrone and Lidocaine?
Combined Depo-Medrone and Lidocaine is developed and marketed by Barts & The London NHS Trust (see full Barts & The London NHS Trust pipeline at /company/barts-the-london-nhs-trust).
Is Combined Depo-Medrone and Lidocaine also known as anything else?
Combined Depo-Medrone and Lidocaine is also known as Methylprednisolone Acetate BP 40mg/mL:, Lidocaine Hydrochloride 2%:.
What development phase is Combined Depo-Medrone and Lidocaine in?
Combined Depo-Medrone and Lidocaine is FDA-approved (marketed).
Related
- Manufacturer: Barts & The London NHS Trust — full pipeline
- Also known as: Methylprednisolone Acetate BP 40mg/mL:, Lidocaine Hydrochloride 2%:
- Compare: Combined Depo-Medrone and Lidocaine vs similar drugs
- Pricing: Combined Depo-Medrone and Lidocaine cost, discount & access